Sort
8,912 grants matching “sars cov 2”
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2
$192,500Kui Li · University Of Tennessee Health Sci Ctr · R21 · FY2023 · AI
Transcriptional regulation of ACE2 and the adaption of SARS-CoV-2
$192,500Yiping Zhu · University Of Rochester · R21 · FY2024 · AI
Impacts of Adaptive Coronavirus Evolution on Viral Membrane Fusion
$192,500Thomas Miller Gallagher · Loyola University Chicago · R21 · FY2024 · AI
Ace2 in the healthy and inflamed taste system
$192,500Lynnette Marie McCluskey · Augusta University · R21 · FY2023 · DC
Administrative Supplement to CGRP's effect on hearing and balance in a mouse model of migraine
$192,500Anne E Luebke · University Of Rochester · R01 · FY2020 · DC
Effect of SARS-CoV-2 on host metabolism and its influence on innate and adaptive immunity
$192,289Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2
$192,260Lawrence James Purpura · Columbia University Health Sciences · K23 · FY2024 · AI
Active and passive humoral immunity to enteric adenovirus infection in Bangladeshi children
$192,260Jennifer Marie Hendrick · University Of Virginia · K23 · FY2025 · AI
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2
$192,102Lawrence James Purpura · Columbia University Health Sciences · K23 · FY2022 · AI
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2
$192,102Lawrence James Purpura · Columbia University Health Sciences · K23 · FY2023 · AI
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
$192,001Robert Blair · Tulane University Of Louisiana · K01 · FY2024 · OD
Elucidating Olfactory Epithelial Anti-Viral Responses in Persistent Post-Viral Olfactory Dysfunction
$191,873Carol H Yan · University Of California, San Diego · K08 · FY2022 · DC
Elucidating Olfactory Epithelial Anti-Viral Responses in Persistent Post-Viral Olfactory Dysfunction
$191,873Carol H Yan · University Of California, San Diego · K08 · FY2023 · DC
Elucidating Olfactory Epithelial Anti-Viral Responses in Persistent Post-Viral Olfactory Dysfunction
$191,873Carol H Yan · University Of California, San Diego · K08 · FY2024 · DC
Elucidating Olfactory Epithelial Anti-Viral Responses in Persistent Post-Viral Olfactory Dysfunction
$191,873Carol H Yan · University Of California, San Diego · K08 · FY2025 · DC
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance Abuse
$191,865Mariana Cherner · University Of California, San Diego · K24 · FY2025 · DA
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance Abuse
$191,865Mariana Cherner · University Of California, San Diego · K24 · FY2024 · DA
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance Abuse
$191,865Mariana Cherner · University Of California, San Diego · K24 · FY2023 · DA
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance Abuse
$191,865Mariana Cherner · University Of California, San Diego · K24 · FY2021 · DA
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance Abuse
$191,865Mariana Cherner · University Of California, San Diego · K24 · FY2022 · DA
Early and long term immunity following SARS-CoV-2 infection in humans
$191,724William Messer · Oregon Health & Science University · R01 · FY2021 · AI
An advanced personal nasal sampler (PNS) to assess occupational exposures to airborne viruses
$191,690Gediminas Mainelis · Rutgers, The State Univ Of N.J. · R21 · FY2022 · OH
Viral Testing Core
$191,519Koen K Van Rompay · University Of California At Davis · U42 · FY2025 · OD
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
$191,325Edward W Boyer · Ohio State University · K24 · FY2023 · DA
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
$191,325Edward W Boyer · Ohio State University · K24 · FY2024 · DA